Skip to content

Addiction: all studies

Page 313 of 857: studies 3,121 to 3,130 of 8,563, newest first. Back to the addiction overview

Research

PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS

Health and Society January 8, 2025 Eduardo D’avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha et al.

Psychedelics have emerged as a promising approach to treating mental disorders, challenging traditional paradigms in psychiatry. This study conducted an integrative literature review to investigate the advances, challenges, and implications of the therapeutic use of these substances, addressing the guiding question: “What are the current scientific perspectives on the use of psychedelics in the...

Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report.

Journal of Psychoactive Drugs January 7, 2025 Matthew Hicks, Heather Zwickey, Ryan Bradley 2 citations

There are currently no evidence-based treatment guidelines for antisocial personality disorder (ASPD). Instead, treatment typically focuses on comorbid conditions. There is currently no literature documenting cases or research, theoretical or otherwise of using ketamine-assisted therapy or any other psychedelic therapy in cases of ASPD. In this case report, a 43-year-old man seeking...

DOI: 10.1080/02791072.2025.2449911 (opens in new tab) Full text (opens in new tab) Antisocial personality disorder Case report Ketamine-assisted psychotherapy Mental health treatment +2

Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.

Current Pain and Headache Reports January 7, 2025 Natalie H Strand, Madeline Whitney, Brooks Johnson et al. 9 citations

Chronic pain affects approximately 1.5 billion people worldwide, representing the leading cause of disability and a significant financial burden on healthcare systems. Conventional treatments, such as opioids and non-steroidal anti-inflammatory drugs, are frequently linked to adverse effects, including dependency and gastrointestinal issues, and often offer limited long-term relief. This review...

Cortical high-frequency oscillations (≈ 110 Hz) in cats are state-dependent and enhanced by a subanesthetic dose of ketamine.

Behavioural Brain Research January 5, 2025 Santiago Castro-Zaballa, Joaquín González, Matías Cavelli et al. 4 citations

Ketamine is an NMDA receptor antagonist that has antidepressant and anesthetic properties. At subanesthetic doses, ketamine induces transient psychosis in humans, and is used to model psychosis in experimental animals. In rodents, subanesthetic doses of ketamine increase the power of high-frequency oscillations (HFO, > 100 Hz) in the electroencephalogram (EEG), a frequency band linked to...

Single-nucleus transcriptomics reveals time-dependent and cell-type-specific effects of psilocybin on gene expression

bioRxiv (Cold Spring Harbor Laboratory) January 4, 2025 Clara Liao, Ethan O'Farrell, Yaman Qalieh et al. 3 citations preprint

ABSTRACT There is growing interest to investigate classic psychedelics as potential therapeutics for mental illnesses. Previous studies have demonstrated that one dose of psilocybin leads to persisting neural and behavioral changes. The durability of psilocybin’s effects suggests that there are likely alterations of gene expression at the transcriptional level. In this study, we performed...

DOI: 10.1101/2025.01.04.631335 (opens in new tab) Psilocybin Gabaergic Excitatory postsynaptic potential Gene expression +2

The clinical use of dream content in modern psychiatry

Australasian Psychiatry January 2, 2025 David Plevin, Virginia Munro 1 citation

ObjectiveThough there is a rich psychoanalytic tradition investigating the content and phenomenology of dreams, the clinical use of this has fallen into widespread disuse. We have undertaken a narrative review of the clinical significance and utility of dream content.FindingsDream content may have useful clinical and prognostic value in a number of neurological and psychiatric conditions,...

DOI: 10.1177/10398562241311926 (opens in new tab) Dream Content measure theory Psychotherapist

Resting State Functional Connectivity of the Default Mode Network During Opioid Use and Cessation in Treatment‐Seeking Persons

European Journal of Neuroscience 2025 Jade Dandurand, Michael D. Stein, B. Surprenant et al.

Resting‐state functional connectivity analyses have been used to examine synchrony in neural networks in substance use disorders (SUDs), with the default mode network (DMN) one of the most studied. Prior research has generally found less DMN synchrony during use and greater synchrony during cessation, although little research has utilized this method with opioid use. This study examined resting...

The Effectiveness of Mindfulness-Based Cognitive Therapy on Positive and Negative Emotions, Sleep Quality, and Rumination in Women with Irritable Bowel Syndrome

Journal of Cognition, Behavior, Learning 2025 Saeedeh Esmaeilzadeh Tarshayeh, Eshagh Samkhaniani

This study aimed to investigate the effectiveness of mindfulness-based cognitive therapy (MBCT) on positive and negative emotions, sleep quality, and rumination among women with irritable bowel syndrome (IBS). This applied quasi-experimental research used a pretest-posttest design with a control group. The statistical population included all women diagnosed with IBS who referred to hospitals...

Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment

JAMA Network Open 2025 Zev Schuman-Olivier, Hannah J. Goodman, Joseph Rosansky et al.

Key Points Question During buprenorphine treatment, does group-based mindfulness training reduce opioid use, craving, and anxiety compared with group recovery support? Findings In this randomized clinical trial including 196 adults prescribed buprenorphine for opioid use disorder, mindfulness was not superior at reducing illicit opioid use compared with an active group intervention with an...

Embodied First-Person Perspective

Phenomenology and Mind 2025 Edoardo Fugali

In this paper I will argue that self-awareness and world-awareness are inherently embodied, with the embodied first-person perspective as their primary structure. Challenging dominant views, I contend that the first-person perspective is not reducible to subjective ownership of experiences or linguistic self-reference but arises from the body’s role as the zero-point of an oriented spatial...